These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 19341847)

  • 21. A collaborative study of the progesterone intrauterine device (Progestasert). The World Health Organization Task Force on Methods for the Regulation of Implantation.
    Newton J; Szontagh F; Lebech P; Rowe P
    Contraception; 1979 Jun; 19(6):575-89. PubMed ID: 487808
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Menstrual flow duration and spotting following Multiload Copper 250 intra-uterine device insertion.
    Goh TH; Ang ES; Yip YC
    J Obstet Gynaecol (Lahore); 1983 Oct; 4(2):127-8. PubMed ID: 12279948
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bleeding pattern difference between levonorgestrel intrauterine system and copper intrauterine devices inserted immediately post-abortion: a multicenter, prospective, observational cohort study in Chinese women.
    Chen X; Li Q; Wang X; Chen J; Lv W; Shi B; Wang H; Luo J; Li J
    Curr Med Res Opin; 2018 May; 34(5):873-880. PubMed ID: 29298525
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effects of a copper-intrauterine device on the uterine artery blood flow in regularly menstruating women.
    Järvelä I; Tekay A; Jouppila P
    Hum Reprod; 1998 Jul; 13(7):1841-5. PubMed ID: 9740436
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The influence of the Gyne-T 380S IUD on menstrual blood loss and iron status.
    Milsom I; Andersson K; Jonasson K; Lindstedt G; Rybo G
    Contraception; 1995 Sep; 52(3):175-9. PubMed ID: 7587189
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Complications among adolescents using copper intrauterine contraceptive devices.
    Rasheed SM; Abdelmonem AM
    Int J Gynaecol Obstet; 2011 Dec; 115(3):269-72. PubMed ID: 21872240
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acceptability of an experimental intracervical device: results of a study controlling for selection bias.
    Shain RN; Ratsula K; Toivonen J; Lähteenmäki P; Luukkainen T; Holden AE; Rosenthal M
    Contraception; 1989 Jan; 39(1):73-84. PubMed ID: 2491982
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influences of copper and design of intrauterine devices on endometrial bleeding in monkeys.
    Shaw ST; Forino RV; Poon CH; Moyer DL
    Contraception; 1976 Jul; 14(1):9-15. PubMed ID: 824096
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A comparison of the delta copper T and the copper T 200 in Bologna, Italy.
    Melega C; Biscontin S; Canedi L; Marchesini FP; Tirelli S; Bartolotti T; Flamigni C
    Acta Eur Fertil; 1986; 17(1):39-41. PubMed ID: 3727892
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term cytologic studies of copper-IUD users.
    Engineer AD; Misra JS; Tandon P
    Acta Cytol; 1981; 25(5):550-6. PubMed ID: 6945020
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Influence of removal of intrauterine contraceptive devices on colonisation of the cervix by actinomyces-like organisms.
    Mao K; Guillebaud J
    Contraception; 1984 Dec; 30(6):535-44. PubMed ID: 6529911
    [TBL] [Abstract][Full Text] [Related]  

  • 32. IUD insertion following induced abortion.
    Querido L; Ketting E; Haspels AA
    Contraception; 1985 Jun; 31(6):603-10. PubMed ID: 3899506
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of prior pregnancy and combined oral contraceptives on baseline menstrual blood loss and bleeding response to intrauterine devices.
    Andrade AT; de Souza JP; Rowe PJ; Shaw ST
    Contraception; 1979 Jul; 20(1):19-26. PubMed ID: 477314
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of copper intrauterine device with levonorgestrel-bearing intrauterine system for post-abortion contraception.
    Bilgehan F; Dilbaz B; Karadag B; Deveci CD
    J Obstet Gynaecol Res; 2015 Sep; 41(9):1426-32. PubMed ID: 26180028
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Five years private practice experience of nulliparous women using copper IUD's.
    Smith RP; Goresky DM; Etchell DM
    Contraception; 1980 Apr; 21(4):335-42. PubMed ID: 7389354
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intrauterine devices: an effective alternative to oral hormonal contraception.
    Prescrire Int; 2009 Jun; 18(101):125-30. PubMed ID: 19637436
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Do insertion-related problems affect subsequent IUD performance?
    Chi IC; Waszak CS; Wilkens LR
    Contraception; 1986 Nov; 34(5):497-503. PubMed ID: 3816233
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A prospective cohort study comparing expulsion after postplacental insertion: the levonorgestrel versus the copper intrauterine device.
    Hinz EK; Murthy A; Wang B; Ryan N; Ades V
    Contraception; 2019 Aug; 100(2):101-105. PubMed ID: 31108053
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Copper-7 intrauterine device (Gravigard). Report of experience].
    Jürgensen O; Stenzel I; Wirth A; Sina D; Taubert HD
    Fortschr Med; 1976 Mar; 94(9):515-21. PubMed ID: 964914
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A randomized clinical trial of the effect of intensive versus non-intensive counselling on discontinuation rates due to bleeding disturbances of three long-acting reversible contraceptives.
    Modesto W; Bahamondes MV; Bahamondes L
    Hum Reprod; 2014 Jul; 29(7):1393-9. PubMed ID: 24812309
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.